Multicenter Study to Evaluate the Efficacy and Safety of Oral ACT-539313 in the Treatment of Adults With Moderate to Severe Binge Eating Disorder

Condition:   Binge-Eating Disorder Interventions:   Drug: ACT-539313;   Drug: Placebo Sponsor:   Idorsia Pharmaceuticals Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials